Tokyo, Japan

Yasushi Takamori

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasushi Takamori: Innovator in Therapeutic Agents for Infections

Introduction

Yasushi Takamori is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in developing therapeutic agents for infections. His work focuses on creating solutions that minimize side effects and combat bacterial resistance.

Latest Patents

Takamori holds 2 patents related to his innovative therapeutic agents. His latest patents include a therapeutic agent for infections that comprises granulysin as an active ingredient. This agent is designed to have minimal side effects and no cytotoxicity, making it a promising option for treating infections. The invention also addresses the challenge of bacterial resistance, providing a treatment method that enhances the killing effects on bacteria while ensuring that bacteria can hardly acquire resistance.

Career Highlights

Throughout his career, Yasushi Takamori has worked at the National Hospital Organization Kinki-chuo Chest Medical Center. His experience in this institution has contributed to his expertise in developing effective therapeutic solutions.

Collaborations

Takamori has collaborated with notable colleagues, including Masaji Okada and Kazuyuki Ogawa. These partnerships have likely enriched his research and development efforts in the field of therapeutic agents.

Conclusion

Yasushi Takamori's innovative work in creating therapeutic agents for infections showcases his commitment to advancing medical science. His contributions are vital in addressing the pressing issues of side effects and bacterial resistance in treatment methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…